IL1B and inflammatory bowel disease: The pharmacological effects of 5-ASA in the treatment of IBD involve inhibition of leukocyte motility, interference of TNFα, TGF- β, IL-1, and NFκB, and promotion of intestinal epithelial cells to maintain normal redox level and self-renewal (Campregher and Gasche 2011).